Trial intelligence / Profile preview

Sodium aescinate enteric-coated capsules for postoperative limb swelling

CTR20171572Phase 2Active

Sponsor
Wuhan Aimin Pharmaceutical
Start
Dec 2017
Modality
Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of escin, sponsored by Wuhan Aimin Pharmaceutical. Started Dec 2017; status: active.

02

Drugs

escin

Beyond the preview

Go deeper on CTR20171572.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20171572.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call